These findings suggest that CD109’s absence amplifies dermal TGF-β signaling and alters the immune cell dynamics within the dermal layer, potentially contributing to a tumor-suppressive microenvironment in early carcinogenesis. The gene discussed is TGFB1; the disease is neoplasm.